These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 29488502

  • 1. [The species composition and sensitivity of pathogenic microflora responsible for the development of otitis externa diffusa to the components of Polidexa].
    Krasnozhen VN, Pokrovskaya EM, Bayazitova LT.
    Vestn Otorinolaringol; 2018; 83(1):65-67. PubMed ID: 29488502
    [Abstract] [Full Text] [Related]

  • 2. Acute otitis externa: an update.
    Schaefer P, Baugh RF.
    Am Fam Physician; 2012 Dec 01; 86(11):1055-61. PubMed ID: 23198673
    [Abstract] [Full Text] [Related]

  • 3. Pooled analysis of two clinical trials comparing the clinical outcomes of topical ciprofloxacin/dexamethasone otic suspension and polymyxin B/neomycin/hydrocortisone otic suspension for the treatment of acute otitis externa in adults and children.
    Rahman A, Rizwan S, Waycaster C, Wall GM.
    Clin Ther; 2007 Sep 01; 29(9):1950-6. PubMed ID: 18035194
    [Abstract] [Full Text] [Related]

  • 4. In vitro evaluation of the synergistic activity of neomycin-polymyxin B association against pathogens responsible for otitis externa.
    Tempera G, Mangiafico A, Genovese C, Giudice E, Mastrojeni S, Nicolosi D, Ferneri PM.
    Int J Immunopathol Pharmacol; 2009 Sep 01; 22(2):299-302. PubMed ID: 19505383
    [Abstract] [Full Text] [Related]

  • 5. Differences in bacteriologic treatment failures in acute otitis externa between ciprofloxacin/dexamethasone and neomycin/polymyxin B/hydrocortisone: results of a combined analysis.
    Dohar JE, Roland P, Wall GM, McLean C, Stroman DW.
    Curr Med Res Opin; 2009 Feb 01; 25(2):287-91. PubMed ID: 19192973
    [Abstract] [Full Text] [Related]

  • 6. Declining susceptibility to neomycin and polymyxin B of pathogens recovered in otitis externa clinical trials.
    Cantrell HF, Lombardy EE, Duncanson FP, Katz E, Barone JS.
    South Med J; 2004 May 01; 97(5):465-71. PubMed ID: 15180022
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Endoscopic photographic comparison of drug delivery by ear-drops and by aerosol spray.
    McGarry GW, Swan IR.
    Clin Otolaryngol Allied Sci; 1992 Aug 01; 17(4):359-60. PubMed ID: 1526058
    [Abstract] [Full Text] [Related]

  • 9. Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with otitis externa.
    Schwartz RH.
    Curr Med Res Opin; 2006 Sep 01; 22(9):1725-36. PubMed ID: 16968576
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of topical ciprofloxacin/dexamethasone versus neomycin/polymyxin B/hydrocortisone for otitis externa.
    Roland PS, Pien FD, Schultz CC, Henry DC, Conroy PJ, Wall GM, Garadi R, Dupre SJ, Potts SL, Hogg LG, Stroman DW, Ciprodex Otic AOE Study Group.
    Curr Med Res Opin; 2004 Aug 01; 20(8):1175-83. PubMed ID: 15324520
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ofloxacin otic solution for treatment of otitis externa in children and adults.
    Jones RN, Milazzo J, Seidlin M.
    Arch Otolaryngol Head Neck Surg; 1997 Nov 01; 123(11):1193-200. PubMed ID: 9366699
    [Abstract] [Full Text] [Related]

  • 13. A group III steroid solution without antibiotic components: an effective cure for external otitis.
    Emgård P, Hellström S.
    J Laryngol Otol; 2005 May 01; 119(5):342-7. PubMed ID: 15949095
    [Abstract] [Full Text] [Related]

  • 14. Otitis externa: clinical comparison of local ciprofloxacin versus local oxytetracycline, polymyxin B, hydrocortisone combination treatment.
    Arnes E, Dibb WL.
    Curr Med Res Opin; 1993 May 01; 13(3):182-6. PubMed ID: 8222746
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Dexamethasone phosphate in antibiotic ear drops for the treatment of acute bacterial otitis externa.
    Mösges R, Schröder T, Baues CM, Sahin K.
    Curr Med Res Opin; 2008 Aug 01; 24(8):2339-47. PubMed ID: 18606053
    [Abstract] [Full Text] [Related]

  • 17. [Efficiency of otoph and polydex ear drops in otitis treatment].
    Luchikhin LA, Magomedov MM, Gorbacheva VA.
    Vestn Otorinolaringol; 1999 Aug 01; (4):32-4. PubMed ID: 10453233
    [No Abstract] [Full Text] [Related]

  • 18. [Combined treatment of external auditory canal diseases in dermatological practice].
    Khamaganova IV, Piven' NP.
    Vestn Otorinolaringol; 2010 Aug 01; (2):66-8. PubMed ID: 20527091
    [No Abstract] [Full Text] [Related]

  • 19. Prospective randomised single-blind controlled trial of glacial acetic acid versus glacial acetic acid, neomycin sulphate and dexamethasone spray in otitis externa and infected mastoid cavities.
    Johnston MN, Flook EP, Mehta D, Mortimore S.
    Clin Otolaryngol; 2006 Dec 01; 31(6):504-7. PubMed ID: 17184455
    [Abstract] [Full Text] [Related]

  • 20. Comparative efficacy of two anti-bacterial/anti-inflammatory formulations (Auricularum otic powder and Dex-Otic drops) in the medical treatment of otitis externa.
    Yaniv E, Shevro J, Nageris B, Lapidot M, Hadar T, Cahani B, Zegerman C.
    Curr Med Res Opin; 2002 Dec 01; 18(8):520-2. PubMed ID: 12564664
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.